Immunology, Internal medicine, Chlamydia trachomatis, Virology and Gynecology are his primary areas of study. Lars Østergaard combines subjects such as Receptor and Case-control study with his study of Immunology. His study in Case-control study is interdisciplinary in nature, drawing from both Malignancy, Acquired immunodeficiency syndrome, microRNA, Essential hypertension and Cohort.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Surgery, Oncology and Vaccination. His studies in Chlamydia trachomatis integrate themes in fields like Nucleic acid amplification technique, Chlamydia, Randomized controlled trial and Genitourinary system. The concepts of his Virology study are interwoven with issues in RNA and IRF3.
Lars Østergaard spends much of his time researching Immunology, Internal medicine, Virology, Chlamydia trachomatis and Cohort study. Antibody, Immune system, Vaccination, Innate immune system and Inflammation are the primary areas of interest in his Immunology study. His Internal medicine research incorporates themes from Gastroenterology, Surgery and Intensive care medicine.
The study incorporates disciplines such as Chlamydia and Obstetrics in addition to Chlamydia trachomatis. His Cohort study research is multidisciplinary, incorporating elements of Epidemiology, Incidence, Hazard ratio, Pediatrics and Cohort. His research in Randomized controlled trial intersects with topics in Placebo and Physical therapy.
Lars Østergaard mainly focuses on Immunology, Internal medicine, Immune system, Virology and Antibody. His studies link Receptor with Immunology. As part of his studies on Internal medicine, Lars Østergaard frequently links adjacent subjects like Surgery.
His study in the field of CD8, T cell, Immunity and Acquired immune system also crosses realms of Cart. His T cell research focuses on Cancer research and how it connects with Lymph. His work deals with themes such as Cervarix, Gardasil and In vivo, which intersect with Virology.
His primary areas of study are Immunology, Virology, Immune system, CD8 and Panobinostat. He has included themes like Agonist and Receptor in his Immunology study. His study explores the link between Virology and topics such as In vivo that cross with problems in Viral replication, Vagina and Transmission.
His CD8 study combines topics in areas such as T cell, Cancer research and Cytokine. Lars Østergaard usually deals with Innate immune system and limits it to topics linked to Cytotoxic T cell and Virus latency. His work in the fields of Immunogenicity overlaps with other areas such as Papillomavirus Vaccines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Hjördis Ó. Atladóttir;Poul Thorsen;Lars Østergaard;Diana E. Schendel.
Journal of Autism and Developmental Disorders (2010)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A Rasmussen;Martin Tolstrup;Christel R Brinkmann;Rikke Olesen.
The Lancet HIV (2014)
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza.
The Lancet (2019)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
Ole S. Søgaard;Mette E. Graversen;Steffen Leth;Rikke Olesen.
PLOS Pathogens (2015)
Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae.
Robert L. Cook;Shari L. Hutchison;Lars Østergaard;R. Scott Braithwaite.
Annals of Internal Medicine (2005)
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia.
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
Martin R. Jakobsen;Rasmus O. Bak;Annika Andersen;Randi K. Berg;Randi K. Berg.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.
Thomas Aagaard Rasmussen;Ole Schmeltz Sogaard;Christel Brinkmann;Fiona Wightman.
Human Vaccines & Immunotherapeutics (2013)
Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns
Trine H. Mogensen;Søren R. Paludan;Mogens Kilian;Lars Østergaard.
Journal of Leukocyte Biology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: